Fariba Némati - Concepedia

Author

Fariba Némati

Institut Curie ORCID

Also Known As

F NEMATI, F Nemati, F NéMATI, F Némati, F. NEMATI, F. Nemati, F. Némati, Fariba Nemati, Fariba Némati, Fariba Némati

293

Publications

4.6K

Citations

H-Index

Concepts

All Affiliations

Institut Curie Inserm Centre National de la Recherche Scientifique Université Paris Sciences et Lettres Université Paris Cité

About

Fariba Némati is an author at Institut Curie specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	22	1.6K
2	Engineering	5	5	339
3	Health Sciences	5	5	226
4	Biomedical Engineering	4	4	172
5	Biochemistry	1	1	290

Fariba Némati

Publications

4.4K

Citations

H-Index

Page 1

	Year	Citations
High-throughput single-cell ChIP-seq identifies heterogeneity of chromatin states in breast cancer Kevin Grosselin, Adeline Durand, Justine Marsolier, Nature Genetics ChromatinChromatin RemodelingTumor HeterogeneityMedicineSingle Cell Sequencing	2019	464
Characterization of a Large Panel of Patient-Derived Tumor Xenografts Representing the Clinical Heterogeneity of Human Colorectal Cancer Sylvia Julien, Ana Merino‐Trigo, Ludovic Lacroix, Clinical Cancer Research	2012	361
PML-Regulated Mitochondrial Metabolism Enhances Chemosensitivity in Human Ovarian Cancers Géraldine Gentric, Yann Kieffer, Virginie Mieulet, Cell Metabolism Metabolic RemodelingHuman Ovarian CancersRedox BiologyTumor BiologyOxidative Stress	2018	290
Polo-like Kinase 1: A Potential Therapeutic Option in Combination with Conventional Chemotherapy for the Management of Patients with Triple-Negative Breast Cancer Virginie Maire, Fariba Némati, Marion Richardson, Cancer Research Breast OncologyTnbc Cell LinesPathologyCell DeathCancer Biology	2012	188
Establishment and Characterization of a Panel of Human Uveal Melanoma Xenografts Derived from Primary and/or Metastatic Tumors Fariba Némati, Xavier Sastre‐Garau, Cécile Laurent, Clinical Cancer Research	2010	170
Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target Nabil Amirouchene-Angelozzi, Fariba Némati, David Gentien, Molecular Oncology	2014	169
Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action AC de Verdière, Catherine Dubernet, Fariba Némati, British Journal of Cancer NanomedicinePolyalkylcyanoacrylate NanoparticlesEngineeringSmart PolymerPolymer-drug Conjugate	1997	167
Peripheral benzodiazepine receptor ligands reverse apoptosis resistance of cancer cells in vitro and in vivo. Didier Decaudin, Maria Castedo, Fariba Némati, PubMed Chemoprevention StrategyApoptosisCell DeathReverse Apoptosis ResistanceCellular Pharmacology	2002	155
BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers Florence Coussy, Rania El Botty, Sophie Château‐Joubert, Science Translational Medicine	2020	132
PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance Élodie Montaudon, Joanna Nikitorowicz-Buniak, Laura Sourd, Nature Communications	2020	122

Page 1